Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB06292_nanopub.RAo_i18xNNC9PibPDXGST_4nHBiLEwxuX2yAWGuEZEbk4#assertion>. }
Showing items 1 to 15 of
15
with 100 items per page.
- drugbank:DB06292 type drugbank_vocabulary:Drug assertion.
- drugbank:DB06292 label "Dapagliflozin [drugbank:DB06292]" assertion.
- drugbank:DB06292 seeAlso farxiga.html assertion.
- drugbank:DB06292 seeAlso DB06292 assertion.
- drugbank:DB06292 description "Dapagliflozin is indicated for the management of diabetes mellitus type 2, and functions to improve glycemic control in adults when combined with diet and exercise. Dapagliflozin is a sodium-glucose cotransporter 2 inhibitor, which prevents glucose reabsorption in the kidney. Using dapagliflozin leads to heavy glycosuria (glucose excretion in the urine), which can lead to weight loss and tiredness. Dapagliflozin was approved by the FDA on Jan 08, 2014." assertion.
- drugbank:DB06292 identifier "drugbank:DB06292" assertion.
- drugbank:DB06292 title "Dapagliflozin" assertion.
- drugbank:DB06292 drugbank_vocabulary:x-cas cas:461432-26-8 assertion.
- drugbank:DB06292 drugbank_vocabulary:drugbank-id "DB06292" assertion.
- drugbank:DB06292 bio2rdf_vocabulary:x-identifiers.org DB06292 assertion.
- drugbank:DB06292 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB06292" assertion.
- drugbank:DB06292 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB06292 bio2rdf_vocabulary:identifier "DB06292" assertion.
- drugbank:DB06292 drugbank_vocabulary:x-wikipedia wikipedia:Dapagliflozin assertion.
- drugbank:DB06292 drugbank_vocabulary:x-kegg kegg:D08897 assertion.